9,10-dimethyl-1,2-benzanthracene has been researched along with equol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, EJ; Kim, GH | 2 |
Belles, CA; Brown, NM; Kim, MO; Lindley, SL; Setchell, KD; Witte, DP; Zimmer-Nechemias, L | 1 |
3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and equol
Article | Year |
---|---|
Hepatoprotective effects of daidzein against 7,12-dimetylbenz[a]anthracene-induced oxidative stress in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Apoptosis; Carcinogens; Cytoprotection; Drug Evaluation, Preclinical; Equol; Female; Glutathione; Isoflavones; Liver; Mice; Mice, Inbred ICR; Oxidative Stress; Phytoestrogens | 2009 |
Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Animals, Newborn; Body Weight; Carcinogens; Disease Models, Animal; Equol; Female; Genistein; Isoflavones; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Organ Size; Phytoestrogens; Rats; Rats, Sprague-Dawley; Stereoisomerism; Time Factors | 2010 |
Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Equol; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley | 2011 |